Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Molecular Profile and Cytomorphological Manifestation of Isolated Y Loss in Myelodysplastic Syndromes

Blood (2018) 132 (Supplement 1): 4358.

https://doi.org/10.1182/blood-2018-99-114216

Published: 2018

Journal Articles

The Role of PPM1D Mutations in Lenalidomide Resistance and Progression in Patients with MDS and Deletion of Chromosome 5q

Blood (2018) 132 (Supplement 1): 4360.

https://doi.org/10.1182/blood-2018-99-114026

Published: 2018

Journal Articles

Prospective Multicenter Phase 3 Study Comparing 5-Azacytidine (5-Aza) Induction Followed By Allogeneic Stem Cell Transplantation Versus Continuous 5-Aza According to Donor Availability in Elderly MDS Patients (55-70 years) (VidazaAllo Study)

Blood (2018) 132 (Supplement 1): 208.

https://doi.org/10.1182/blood-2018-99-115932

Published: 2018

Journal Articles

Real Life Dates of Chronic Lymphocytic Leukemia (CLL) in Germany. Interim Analysis of 234 Consecutively New Diagnosed Patients in a German Epidemiological-Clinical Register

Dietrich Kämpfe, MD, Harald Stein, MD PhD Dr. h.c., Roshanak Bob, MD, Sebastian Böttcher, Joerg Brenn, Agnes Knopp, MD, Thomas Haverkamp, MD, Christoph Schulte, MD, Detlef Haase, MD PhD

Blood (2018) 132 (Supplement 1): 2264.

https://doi.org/10.1182/blood-2018-99-110618

Published: 2018

Journal Articles

Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS

Andrea Kuendgen, MD, Meritxell Nomdedeu, Heinz Tuechler, Guillermo Garcia-Manero, MD, Rami S. Komrokji, MD, Mikkael A. Sekeres, MD MS, Matteo Giovanni Della Porta, Alan F. List, MD, Mario Cazzola, Amy E. DeZern, MD, Gail J. Roboz, MD, David P. Steensma, MD, Arjan A. Van de Loosdrecht, MD PhD, Hartmut Döhner, MD, Xavier Calvo, MD, Sabine Blum, Arturo Pereira, MD PhD, Peter Valent, Dolors Costa, Aristoteles Giagounidis, Luis Benlloch, Uwe Platzbecker, Carme Pedro, MD, Michael Lübbert, Itziar Oiartzabal, Javier Grau, Maria Díez-Campelo, María Teresa Cedena, Sigrid Machherndl-Spandl, MD, Maria López-Pavía, Claudia D. Baldus, MD, Montserra Martinez-de-Sola, Reinhard Stauder, MD MSc, Brayan Merchan, Christina Ganster, Thomas Schroeder, Barbara Hildebrandt, Jordi Esteve, MD PhD, Benet Nomdedeu, Francesc Cobo, Francesc Sole, PhD, Rainer Haas, MD, Ulrich Germing, MD, Peter L Greenberg, MD, Detlef Haase, MD PhD, Guillermo Sanz

Blood (2018) 132 (Supplement 1): 3103.

https://doi.org/10.1182/blood-2018-99-118215

Published: 2018

Journal Articles

Telomere Length Of Granulocytes Significantly Increases During The First Six Months Of Lenalidomide Treatment In Patients With Isolated 5q- Syndrome

Fabian Beier, MD, Ulrich Germing, MD, Guntram Büsche, MD, Patrick Ziegler, PhD, Stefan Wilop, MD, Lucia Vankann, Norbert Gattermann, MD, Uwe Platzbecker, MD, PhD, Aristoteles Giagounidis, MD, PhD, Katharina S. Götze, MD, Wolf-Karsten Hofmann, Detlef Haase, MD, PhD, Hans Kreipe, MD, Jens Panse, MD, Tim H. Brümmendorf, MD

Blood (2013) 122 (21): 2781.

https://doi.org/10.1182/blood.V122.21.2781.2781

Published: 2013

Journal Articles

Cytogenetic Risk Features in MDS-Update and Present State.

Blood (2009) 114 (22): 2772.

https://doi.org/10.1182/blood.V114.22.2772.2772

Published: 2009

Journal Articles

Significant Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS and Sequential Anlyses of BFU-E Under Chelation Therapy.

Julia Hartmann, Ursula Sinzig, Gerald Wulf, MD, Lorenz Trümper, Frank Konietschke, Stephanie Fischer, Detlef Haase, MD, PhD

Blood (2009) 114 (22): 3826.

https://doi.org/10.1182/blood.V114.22.3826.3826

Published: 2009

Journal Articles

Survival, Prognostic Factors, and Rates of Leukemic Transformation in a Multicenter Study of 303 Untreated Patients with MDS and Del(5q).

Blood (2009) 114 (22): 945.

https://doi.org/10.1182/blood.V114.22.945.945

Published: 2009

Journal Articles

A Polymorphism Study on Detoxification and DNA Repair Genes in 700 MDS Patients Demonstrates An Association Between Genotype and An Aberrant Karyotype

C. Seedhouse, Stephanie Fischer, Christina Ganster, Christa Fonatsch, Peter Valent, MD, Ulrich Germing, Nigel H. Russell, MD, Detlef Haase, MD, PhD

Blood (2008) 112 (11): 2690.

https://doi.org/10.1182/blood.V112.11.2690.2690

Published: 2008

Journal Articles

High Resolution Genomic Mapping of Breast Cancer Derived T-MDS/TAML

Azim M Mohamedali, PhD, Natalie Twine, MSc, Joop Gaken, PhD, Nigel Westwood, PhD, CSci, FIBMS, Nicholas Lea, PhD, Rajani Chelliah, MSc, Detlef Haase, MD, PhD, Ghulam J Mufti, FRCP, FRCPath

Blood (2008) 112 (11): 2692.

https://doi.org/10.1182/blood.V112.11.2692.2692

Published: 2008

Journal Articles

Evidence for a Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS

Julia Hartmann, Ursula Sinzig, Gerald Wulf, MD, PhD, Lorenz H. Truemper, MD, PhD, Friederike Braulke, MD, Frank Konietschke, Detlef Haase, MD, PhD

Blood (2008) 112 (11): 2694.

https://doi.org/10.1182/blood.V112.11.2694.2694

Published: 2008

Journal Articles

Analysing Circulating CD34+ Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities

Friederike Braulke, MD, Julie Schanz, MD, Lorenz H. Truemper, MD, PhD, Detlef Haase, MD, PhD

Blood (2008) 112 (11): 2696.

https://doi.org/10.1182/blood.V112.11.2696.2696

Published: 2008

Journal Articles

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.

Blood (2008) 112 (11): 1649.

https://doi.org/10.1182/blood.V112.11.1649.1649

Published: 2008

Journal Articles

Role of Etoposide in Combination with All- Trans Retinoic Acid in the Treatment of Elderly Patients with Acute Myeloid Leukemia and NPM1 Mutation

Marie-Luise Hütter, Konstanze Döhner, Ingo G.H. Schmidt-Wolf, Francisco Del Valle, Björn Heydrich, Wolfgang Heit, Walter Fiedler, Michael Pfreundschuh, MD, PhD, Gudrun Russ, Martin Bentz, Aruna Raghavachar, Detlef Haase, MD, PhD, Wolfram Brugger, MD, Katharina Götze, Silja Groner, Hartmut Döhner, Richard Schlenk

Blood (2008) 112 (11): 559.

https://doi.org/10.1182/blood.V112.11.559.559

Published: 2008

Journal Articles

Coalescence of the German-Austrian and IMRAW Cytogenetic MDS Databases: Modification of Patient Risk Groups.

Christian Steidl, MD, Julie Schanz, MD, Michelle M. Le Beau, PhD, John M. Bennett, MD, Ulrich Germing, MD, Peter L. Greenberg, MD, Detlef Haase, MD, PhD

Blood (2007) 110 (11): 2468.

https://doi.org/10.1182/blood.V110.11.2468.2468

Published: 2007

Journal Articles

Evidence for an Underestimation of the Prognostic Impact of Poor Cytogenetics within the IPSS.

Detlef Haase, MD, PhD, Ulrich Germing, MD, PhD, Julie Schanz, MD, Michael Pfeilstoecker, MD, PhD, Barbara Hildebrandt, PhD, Michael Luebbert, MD, PhD, Aristoteles Giagounidis, MD, Carlo Aul, MD, PhD, Lorenz Truemper, MD, PhD, Thomas Mueller, PhD, Peter Valent, MD, PhD, Norbert Gattermann, MD, PhD, Christa Fonatsch, PhD, Otto Krieger, MD, PhD, Reinhard Stauder, MD, Christian Steidl, MD

Blood (2006) 108 (11): 252.

https://doi.org/10.1182/blood.V108.11.252.252

Published: 2006

Journal Articles

New and Comprehensive Cytogenetic Prognostication and Categorization in MDS.

Detlef Haase, MD, PhD, Ulrich Germing, MD, PhD, Julie Schanz, MD, Michael Pfeilstoecker, MD, PhD, Thomas Noesslinger, MD, Barbara Hildebrandt, PhD, Andrea Kuendgen, MD, Michael Luebbert, MD, PhD, Aristoteles Giagounidis, MD, Carlo Aul, MD, PhD, Lorenz Truemper, MD, PhD, Thomas Mueller, PhD, Peter Valent, MD PhD, Christa Fonatsch, MD, PhD, Christian Steidl, MD

Blood (2006) 108 (11): 248.

https://doi.org/10.1182/blood.V108.11.248.248

Published: 2006

Journal Articles

Different Patterns of Cytogenetic Evolution in CML Treated with Imatinib.

Detlef Haase, MD, PhD, Christian Steidl, MD, Anne Bierbaum, Ulrike Soeling, MD, Lorenz Truemper, MD, PhD, Frank Griesinger, MD, PhD

Blood (2005) 106 (11): 4496.

https://doi.org/10.1182/blood.V106.11.4496.4496

Published: 2005

Journal Articles

Sequential Cytogenetic Analyses of 577 Patients with Myelodysplastic Syndromes: Correlations between Initial Karyotype, Cytogenetic Dynamics, and Clinical Course.

Christian Steidl, MD, Rainer Schabla, MD, Ulrich Germing, MD, PhD, Barbara Hildebrandt, PhD, Thomas Noesslinger, MD, Michael Pfeilstoecker, MD, PhD, Aristoteles Giagounidis, MD, PhD, Regina Kunzmann, PhD, Peter Haas, MD, Michael Luebbert, MD, PhD, Lorenz Truemper, MD, PhD, Detlef Haase, MD, PhD

Blood (2005) 106 (11): 2531.

https://doi.org/10.1182/blood.V106.11.2531.2531

Published: 2005

NARROW

Molecular Profile and Cytomorphological Manifestation of Isolated Y Loss in Myelodysplastic Syndromes

The Role of PPM1D Mutations in Lenalidomide Resistance and Progression in Patients with MDS and Deletion of Chromosome 5q

Prospective Multicenter Phase 3 Study Comparing 5-Azacytidine (5-Aza) Induction Followed By Allogeneic Stem Cell Transplantation Versus Continuous 5-Aza According to Donor Availability in Elderly MDS Patients (55-70 years) (VidazaAllo Study)

Real Life Dates of Chronic Lymphocytic Leukemia (CLL) in Germany. Interim Analysis of 234 Consecutively New Diagnosed Patients in a German Epidemiological-Clinical Register

Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS

Telomere Length Of Granulocytes Significantly Increases During The First Six Months Of Lenalidomide Treatment In Patients With Isolated 5q- Syndrome

Cytogenetic Risk Features in MDS-Update and Present State.

Significant Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS and Sequential Anlyses of BFU-E Under Chelation Therapy.

Survival, Prognostic Factors, and Rates of Leukemic Transformation in a Multicenter Study of 303 Untreated Patients with MDS and Del(5q).

A Polymorphism Study on Detoxification and DNA Repair Genes in 700 MDS Patients Demonstrates An Association Between Genotype and An Aberrant Karyotype

High Resolution Genomic Mapping of Breast Cancer Derived T-MDS/TAML

Evidence for a Suppression of the Colony Forming Capacity of Erythroid Progenitors by Iron Overload in Patients with MDS

Analysing Circulating CD34+ Cells by FISH Is Representative for the Clone Size in Bone Marrow in MDS Patients Under Different Therapy Modalities

Prognostic Impact of Additional Chromosomal Aberrations (ACA) to 5q- in Patients with primary Myelodysplastic Syndrome.

Role of Etoposide in Combination with All- Trans Retinoic Acid in the Treatment of Elderly Patients with Acute Myeloid Leukemia and NPM1 Mutation

Coalescence of the German-Austrian and IMRAW Cytogenetic MDS Databases: Modification of Patient Risk Groups.

Evidence for an Underestimation of the Prognostic Impact of Poor Cytogenetics within the IPSS.

New and Comprehensive Cytogenetic Prognostication and Categorization in MDS.

Different Patterns of Cytogenetic Evolution in CML Treated with Imatinib.

Sequential Cytogenetic Analyses of 577 Patients with Myelodysplastic Syndromes: Correlations between Initial Karyotype, Cytogenetic Dynamics, and Clinical Course.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only